Form 4: Structure Therapeutics Director, Daniel G. Welch, Acquires Share Options
SEC Form 4
Director Daniel G. Welch acquired share options in Structure Therapeutics Inc. on June 25, 2024.
Summary
- On June 25, 2024, Daniel G. Welch, a director of Structure Therapeutics Inc., acquired share options to purchase 37,500 ordinary shares.
- The exercise price of the options is $13.32 per share, based on the fair market value on the grant date.
- The options vest in equal monthly installments over 12 months following the grant date.
- The options expire on June 24, 2034.
- Following the transaction, Welch directly owns 37,500 derivative securities.
Sentiment
Score: 5
Explanation: The sentiment is neutral as it reflects a routine transaction of stock option grants to a company director.
Future Outlook
NA
Industry Context
This filing reflects a standard practice of granting stock options to directors as part of their compensation, aligning their interests with those of the shareholders.
Stakeholder Impact
- The transaction has a minor positive impact on shareholders as it aligns the director's interests with the company's performance.
Key Dates
| Date | Description |
|---|---|
| 06/25/2024 | Date of the earliest transaction: acquisition of share options. |
| 06/25/2024 | Grant date of the share options. |
| 06/24/2034 | Expiration date of the share options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.